Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;242(9):2123-2133.
doi: 10.1007/s00213-025-06790-2. Epub 2025 Apr 17.

Assessment of abuse potential of furanylfentanyl and tetrahydrofuranylfentanyl

Affiliations

Assessment of abuse potential of furanylfentanyl and tetrahydrofuranylfentanyl

Yuanyuan Chen et al. Psychopharmacology (Berl). 2025 Sep.

Abstract

Rational: Furanylfentanyl and tetrahydrofuranylfentanyl (THF-F) have been emerging in numerous intoxication and overdose cases in recent years. However, there remains a data deficiency regarding the abuse potential of these novel fentanyl analogs.

Objectives: This study was designed to systematically assess the abuse potential of furanylfentanyl and THF-F.

Methods: In this study, we evaluated the abuse potential of furanylfentanyl and THF-F via the conditioned place preference (CPP), drug self-administration, drug discrimination, and naloxone-precipitated withdrawal experiments with fentanyl as a reference.

Results: Results from CPP experiments indicated that furanylfentanyl and THF-F could induce CPP at minimum doses of 0.1 mg/kg and 3 mg/kg, respectively. These doses were 1 time and 30 times that of fentanyl (0.1 mg/kg). Furanylfentanyl elicited stable self-administration responses at 2.5 µg/kg/infusion, whereas THF-F did so at 50 µg/kg/infusion. In the drug-substitution test, furanylfentanyl and THF-F induced the maximum number of infusions at 1.10 µg/kg and 12.5 µg/kg, respectively, which were 1 time and 10 times that of fentanyl (1.21 µg/kg). In drug discrimination tests, all three substances were fully substituted for the discriminative-stimulus effects of heroin dose-dependently. The substitution potency of furanylfentanyl (ED50 = 2.68 µg/kg) was similar to that of fentanyl (ED50 = 2.66 µg/kg), while THF-F (ED50 = 36.32 µg/kg) was 14-fold less potent than fentanyl. Repeated administration of furanylfentanyl and THF-F produced naloxone-precipitated withdrawal symptoms. Thus, furanylfentanyl exhibited comparable potency to fentanyl in terms of rewarding, reinforcing, and subjective effects, while THF-F had reduced potency in these effects. Both of them had physical dependence.

Conclusions: Taken together, our study presented new evidence indicating that furanylfentanyl and THF-F exhibit significant abuse potential in rodent models, which provides experimental data for the control. Furthermore, our study offered valuable information for future studies into the addictive properties of structurally modified fentanyl analogs.

Keywords: Conditioned place preference; Drug discrimination; Fentanyl; Furanylfentanyl; Naloxone-precipitated withdrawal; Self-administration; Tetrahydrofuranylfentanyl.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: All procedures followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Conflict of interest: The authors declare no conflict of interest related to this work.

Similar articles

References

    1. Anand JP, Boyer BT, Mosberg HI et al (2016) The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice. Psychopharmacology 233:2479–2487. https://doi.org/10.1007/s00213-016-4296-8 - DOI
    1. Åstrand A, Vikingsson S, Jakobsen I et al (2020) Activation of the µ-opioid receptor by alicyclic fentanyls: changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure. Drug Test Anal. https://doi.org/10.1002/dta.2906 - DOI
    1. Barbosa LM, Santos JM, de Morais DR et al (2019) Fast UHPLC-MS/MS method for analysis of furanylfentanyl in different seized blotter papers. Drug Test Anal 11:178–183. https://doi.org/10.1002/dta.2472 - DOI
    1. Belin-Rauscent A, Fouyssac M, Bonci A et al (2016) How preclinical models evolved to resemble the diagnostic criteria of drug addiction. Biol Psychiatry 79:39–46. https://doi.org/10.1016/j.biopsych.2015.01.004 - DOI
    1. Bilel S, Azevedo Neto J, Arfè R et al (2022) In vitro and in vivo pharmaco-dynamic study of the novel Fentanyl derivatives: Acrylfentanyl, Ocfentanyl and furanylfentanyl. Neuropharmacology 209:109020. https://doi.org/10.1016/j.neuropharm.2022.109020 - DOI

LinkOut - more resources